No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
FTRE Fortrea Holdings
- 26.380
- +0.070+0.27%
Close May 22 16:00 ET
- 26.390
- +0.010+0.04%
Post 19:09 ET
2.36BMarket Cap-694210P/E (TTM)
26.880High25.700Low1.41MVolume26.380Open26.310Pre Close37.06MTurnover1.85%Turnover RatioLossP/E (Static)89.40MShares41.02052wk High1.47P/B2.02BFloat Cap24.92552wk Low--Dividend TTM76.46MShs Float41.020Historical High--Div YieldTTM4.49%Amplitude24.925Historical Low26.262Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Fortrea Holdings Inc : Jefferies Cuts Target Price to $36.5 From $44
Express News | Fortrea Appoints Machelle Sanders to Board of Directors
Express News | Starboard Value LP: Change in Holdings Are as of March 31, 2024 and Compared With the Previous Quarter Ended as of December 31, 2023
Express News | Starboard Value LP Cuts Share Stake in Fortrea Holdings Inc by 30.2% to 5.3 Mln Shares
Fortrea Holdings Is Maintained at Underperform by B of A Securities
Fortrea Holdings Is Maintained at Underperform by B of A Securities
Fortrea Holdings Price Target Cut to $27.00/Share From $33.00 by B of A Securities
Fortrea Holdings Price Target Cut to $27.00/Share From $33.00 by B of A Securities
Comments
Petrus Advisers views Criteo as an 'attractive investment opportunity' that could be strengthened by requested actions. Ocular Therapeutix's leadership changes are seen as a positive step towards becoming a leader in retina care. Starboard previously labeled Fortrea shares as 'undervalued' and an 'attractive investment opportunity'.
Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors -- Barrons.com 1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg